País: Estados Unidos
Língua: inglês
Origem: NLM (National Library of Medicine)
DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40) (DIPHENHYDRAMINE - UNII:8GTS82S83M)
Micro Labs Limited
INTRAMUSCULAR
PRESCRIPTION DRUG
Diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. For amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. For active treatment of motion sickness. For use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. This drug should not be used in neonates or premature infants. Because of the higher risk of antihistamines for infan
Diphenhydramine Hydrochloride Injection, USP in parenteral form is supplied as: Sterile, pyrogen-free solution containing 50 mg diphenhydramine hydrochloride USP in a 1 mL amber color glass ampule with yellow bands and white OPC mark, and available in packages of ten packed in a PVC rondo tray in a single carton. 1 mL fill in 1 mL Ampule NDC 42571-169-54 Carton of 10 x 1 mL Ampule NDC 42571-169-55 Clear, colorless solution, free from any visible particles, no visible leaks or damage to the container closure system filled in tubular USP Type I glass vials. 1 mL fill in 2 mLVial NDC 42571-337-95 Carton of 25 x 1 mL Vial NDC 42571-337-87 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from freezing and light. Retain in carton until time of use. Rx only Manufactured by: Micro Labs Limited Bangalore-560 099, India. Manufactured for: Micro Labs USA Inc. Basking Ridge, NJ 07920 Revised: September 2018
Abbreviated New Drug Application
DIPHENHYDRAMINE - DIPHENHYDRAMINE HYDROCHLORIDE INJECTION, SOLUTION MICRO LABS LIMITED ---------- DESCRIPTION Diphenhydramine hydrochloride USP is an antihistamine drug having the chemical name 2-(Diphenylmethoxy)-N,N-dimethylethylamine hydrochloride. It occurs as a white, crystalline powder, is freely soluble in water and alcohol and has a molecular weight of 291.82. The molecular formula is C H NO • HCI. The structural formula is as follows: Diphenhydramine hydrochloride USP in the parenteral form is a sterile, pyrogen-free solution available in a concentration of 50 mg of diphenhydramine hydrochloride USP per mL. The solutions for parenteral use have been adjusted to a pH between 4 and 6.5 with either sodium hydroxide or hydrochloric acid. CLINICAL PHARMACOLOGY Diphenhydramine hydrochloride is an antihistamine with anticholinergic (drying) and sedative side effects. Antihistamines appear to compete with histamine for cell receptor sites on effector cells. Diphenhydramine hydrochloride in the injectable form has a rapid onset of action. Diphenhydramine hydrochloride is widely distributed throughout the body, including the CNS. A portion of the drug is excreted unchanged in the urine, while the rest is metabolized via the liver. Detailed information on the pharmacokinetics of Diphenhydramine Hydrochloride Injection is not available. INDICATIONS AND USAGE Diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. ANTIHISTAMINIC For amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when 17 21 oral therapy is impossible or contraindicated. MOTION SICKNESS For active treatment of motion sickness. ANTIPARKINSONISM For use in parkinsonism, when ora Leia o documento completo